|
ZZZ3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70210537173443E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93979999840721E-08 |
| Normal-vs-Stage2 |
1.75792999999036E-05 |
| Normal-vs-Stage3 |
1.00520003432081E-09 |
| Normal-vs-Stage4 |
2.38569997090821E-09 |
| Stage1-vs-Stage2 |
6.043000E-01 |
| Stage1-vs-Stage3 |
9.712200E-02 |
| Stage1-vs-Stage4 |
1.475840E-02 |
| Stage2-vs-Stage3 |
5.166600E-01 |
| Stage2-vs-Stage4 |
2.073600E-01 |
| Stage3-vs-Stage4 |
4.290400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.72569785922883E-11 |
| Normal-vs-AfricanAmerican |
1.996760E-03 |
| Normal-vs-Asian |
1.54269999996792E-07 |
| Caucasian-vs-AfricanAmerican |
4.432600E-01 |
| Caucasian-vs-Asian |
7.642800E-01 |
| AfricanAmerican-vs-Asian |
3.440600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50880000504961E-08 |
| Normal-vs-Female |
9.01939634090354E-11 |
| Male-vs-Female |
6.658400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21770000030652E-07 |
| Normal-vs-Age(41-60Yrs) |
8.47219960853351E-10 |
| Normal-vs-Age(61-80Yrs) |
5.24999999029774E-09 |
| Normal-vs-Age(81-100Yrs) |
1.724190E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.255600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.196400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.094600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.531800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.136200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.469200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.005700E-02 |
| Classical-VS-Follicular |
5.013600E-01 |
| Classical-VS-Other |
9.599000E-01 |
| Classical-VS-Normal |
3.09639999973577E-07 |
| Tall-VS-Follicular |
3.134100E-02 |
| Tall-VS-Other |
3.612000E-01 |
| Tall-VS-Normal |
2.9851999983066E-08 |
| Follicular-VS-Other |
8.039800E-01 |
| Follicular-VS-Normal |
9.8493999999949E-05 |
| Other-VS-Normal |
3.335900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.51630002682191E-09 |
| Normal-vs-N1 |
4.33710000136145E-08 |
| N0-vs-N1 |
1.781350E-01 |
|
|
